A review of the postoperative lymphatic leakage

By -

 

Executive Summary

Postoperative lymphatic leakage is a rare but significant iatrogenic complication resulting from the trauma of lymphatic channels during surgical procedures. This condition encompasses a variety of clinical manifestations, categorized primarily by the nature of the fluid (clear lymph vs. milky chyle) and the site of accumulation. While many instances are self-limiting and asymptomatic, severe cases can lead to profound nutritional deficiency, immunological dysfunction, and prolonged hospitalization.

Diagnosis relies on biochemical analysis—specifically triglyceride levels—and imaging techniques such as lymphangiography and lymphoscintigraphy. Management follows a "step-up" approach, prioritizing conservative treatments such as medium-chain triglyceride (MCT) diets, total parenteral nutrition (TPN), and somatostatin analogues. Surgical intervention, including ligation or the application of fibrin glue, is reserved for refractory cases or high-volume leaks exceeding 1,000–1,500 ml per day.

1. Physiological Foundations of Lymphatic Circulation

The lymphatic system serves three primary functions: draining proteins and excess interstitial fluid, regulating immune responses, and absorbing lipids from the intestine.

Flow Characteristics

  • Volume: Approximately 3 to 5 Liters of lymph fluid (60 to 190 ml per hour) pass through the thoracic duct during digestion.

  • Dietary Impact: Fasting can reduce flow to less than 1 ml/min, whereas a normal diet can increase it to over 200 ml/min.

  • Origin: 50% to 90% of lymph in the cisterna chyli and thoracic duct originates from the liver and intestines.

Key Anatomical Entities

  • Cisterna Chyli: A saccular aneurysm that marks the termination of retroperitoneal lymphatic pathways and the start of the thoracic duct. It is replaced by a variable lymphatic plexus in 50% of cases.

  • Thoracic Duct: Typically ends at the subclavian veins. Anatomical variations exist, including a visible right-sided duct (4% incidence) or a double-branched structure.

  • Chyle: A mixture of lymph and chylomicrons formed after the absorption of long-chain fatty acids (greater than 10 carbon atoms) by the small intestine. It is characterized as milky white, odorless, and bacteriostatic.

2. Classification of Postoperative Lymphatic Leakage

The document categorizes leakage based on fluid composition and the anatomical location of the accumulation.

Lymph-Based Leakage (Clear/Straw-Colored)

Type

Description

Lymphatic Ascites

Clear fluid accumulation in the peritoneal cavity; biochemical composition similar to serum but low in triglycerides.

Lymphocele

A cystic pocket of lymph fluid at the leakage site, often following pelvic lymphadenectomy or renal transplantation.

Lymphorrhea

Exudation of lymph through a skin wound or soft tissue trauma.

Lymphatic Fistula

An objective communication (cutaneous or peritoneal) identified via imaging; typically forms after 48 hours of continuous leakage.

Chyle-Based Leakage (Milky/Triglyceride-Rich)

Type

Description

Chylous Ascites

Pathologic accumulation of chyle in the peritoneal cavity; triglyceride levels typically exceed 200 mg/dl.

Chyloretroperitoneum

Chyle restricted to the retroperitoneal lacuna, often misdiagnosed as chylous ascites.

Chylothorax

Accumulation of chyle in the pleural space due to thoracic duct or branch injury.

Chylorrhea

Chyle exudation through a wound; often confused with lymphorrhea in clinical reporting.


3. Clinical Incidence and Risk Factors

The incidence of lymphatic leakage varies significantly based on the surgical site and the complexity of the dissection.

  • Abdominal Aortic Surgery: The most common etiology for chylous complications, accounting for 81% of cases.

  • Inguinal Lymph Node Dissection (ILND): High incidence of lymphocele, ranging from 5% to 87%.

  • Gynecological Procedures: Pelvic and para-aortic lymphadenectomy for cancers show a lymphatic ascites incidence of 2.7% to 4.5%.

  • Thoracic Surgery: Esophagectomy carries a chylothorax risk of 2.1% to 2.5%, while pulmonary resections range from 1.4% to 4%.

  • Laparoscopic vs. Open Surgery: Laparoscopic procedures may carry a higher risk of unrecognized injury because CO2 pressure can mask leaks during the operation.

Key Risk Factors: High Body Mass Index (BMI), number of resected lymph nodes, preoperative chemotherapy, and the presence of lymphatic metastases.

4. Complications and Diagnosis

Impact of Leakage

The loss of fluid, triglycerides, lymphocytes, and immunoglobulins leads to:

  • Dehydration and nutritional deficiency (hypoalbuminemia).

  • Immunologic dysfunction and increased infection rates.

  • Physical compression of vital structures.

  • Prolonged hospital stays, averaging 12.4 to 20.4 days.

Diagnostic Tools

  1. Diagnostic Paracentesis: The "gold standard" for biochemical confirmation. Findings include triglyceride-rich fluid (2 to 8-fold higher than plasma) and high lymphocyte counts.

  2. Oral Contrast Test: Administration of a high-fat meal (e.g., double cream) to turn drainage milky, facilitating site identification.

  3. Lymphangiography: Real-time visualization using dyes (Patent Blue V, ICG) or ethiodized oil. It can be therapeutic, as the contrast may induce fibrosis to close the leak.

  4. Lymphoscintigraphy: Uses 99mTechnetium-colloid to monitor lymph flow and identify defects, reflux, or fistulas.

5. Management Strategies

Treatment is generally individualized and follows a conservative-first approach, which is successful in 66% to 77% of patients.

Conservative Treatment

  • Dietary Modification:

    • MCT Diet: Medium-chain triglycerides are absorbed directly into the portal system, bypassing the lymphatic channels and reducing flow.

    • Total Parenteral Nutrition (TPN): Provides complete bowel rest and decreases lymph production while correcting metabolic impairments.

  • Pharmacotherapy:

    • Somatostatin/Octreotide: Highly effective in reducing high-output leaks by inhibiting gastrointestinal secretions and potentially inducing lymphatic vessel contraction. Drastic output reductions often occur within 24 to 72 hours.

  • Wound Care: Negative Pressure Wound Therapy (NPWT) is utilized for external lymphorrhea to promote granulation and reduce bacterial counts.

  • Sclerotherapy: Injection of agents (ethanol, doxycycline, povidone-iodine) into lymphoceles after drainage to prevent recurrence (88%–100% success rate).

Surgical Intervention

Surgery is recommended if drainage exceeds 1,000–1,500 ml/day for more than 5 days or if conservative measures fail after 2 weeks.

  • Direct Ligation: Suture ligation of the disrupted channel.

  • Fibrin Glue: Use of adhesives (BioGlue, Floseal) to seal potential leakage sites when the specific source cannot be identified.

  • Peritoneovenous Shunt: A measure for treating refractory lymphatic ascites.

Conclusion

Postoperative lymphatic leakage, though complex, is largely a self-limiting condition if managed with appropriate conservative protocols. Accurate classification between lymph and chyle is critical, as it dictates the efficacy of specific treatments like MCT diets and somatostatin analogues. Early identification and a structured step-up approach are essential to minimizing long-term metabolic and immunological complications.